Desmoteplase and imaging science

被引：6

作者：

Hill, Michael D. ^{[1
]}

机构：

[1] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary Stroke Program, Calgary, AB T2N 1N4, Canada

来源：

LANCET NEUROLOGY | 2009年 / 8卷 / 02期

关键词：

ACUTE ISCHEMIC-STROKE; PERFUSION-DIFFUSION MISMATCH; THROMBOLYSIS; ALTEPLASE; PENUMBRA; TRIAL; SIZE;

D O I：

10.1016/S1474-4422(08)70268-0

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：126 / 128

页数：3

共 12 条

[1] Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].

Albers, Gregory W. ;

Thijs, Vincent N. ;

Wechsle, Lawrence ;

Kemp, Stephanie ;

Schlaug, Gottfried ;

Skalabrin, Elaine ;

Bammer, Roland ;

Kakuda, Wataru ;

Lansberg, Maarten G. ;

Shuaib, Ashfaq ;

Coplin, William ;

Hamilton, Scott ;

Moseley, Michael ;

Marks, Michael P. .

ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517

[2] Rapid assessment of perfusion-diffusion mismatch [J].

Butcher, Ken ;

Parsons, Mark ;

Allport, Louise ;

Lee, Sang Bong ;

Barber, P. Alan ;

Tress, Brian ;

Donnan, Geoffrey A. ;

Davis, Stephen M. .

STROKE, 2008, 39 (01) :75-81

[3] Refining the perfusion-diffusion mismatch hypothesis [J].

Butcher, KS ;

Parsons, M ;

MacGregor, L ;

Barber, PA ;

Chalk, J ;

Bladin, C ;

Levi, C ;

Kimber, T ;

Schultz, D ;

Fink, J ;

Tress, B ;

Donnan, G ;

Davis, S .

STROKE, 2005, 36 (06) :1153-1159

[4] Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial [J].

Davis, Stephen M. ;

Donnan, Geoffrey A. ;

Parsons, Mark W. ;

Levi, Christopher ;

Butcher, Kenneth S. ;

Peeters, Andre ;

Barber, P. Alan ;

Bladin, Christopher ;

De Silva, Deidre A. ;

Byrnes, Graham ;

Chalk, Jonathan B. ;

Fink, John N. ;

Kimber, Thomas E. ;

Schultz, David ;

Hand, Peter J. ;

Frayne, Judith ;

Hankey, Graeme ;

Muir, Keith ;

Gerraty, Richard ;

Tress, Brian M. ;

Desmond, Patricia M. .

LANCET NEUROLOGY, 2008, 7 (04) :299-309

[5] Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset [J].

Furlan, AJ ;

Eyding, D ;

Albers, GW ;

Al-Rawi, Y ;

Lees, KR ;

Rowley, HA ;

Sachara, C ;

Soehngen, M ;

Warach, S ;

Hacke, W .

STROKE, 2006, 37 (05) :1227-1231

[6] Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study [J].

Guadagno, JV ;

Warburton, EA ;

Aigbirhio, FI ;

Smielewski, P ;

Fryer, TD ;

Harding, S ;

Price, CJ ;

Gillard, JH ;

Carpenter, TA ;

Baron, JC .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (11) :1249-1254

[7] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].

Hacke, W ;

Albers, G ;

Al-Rawi, Y ;

Bogousslavsky, J ;

Davalos, A ;

Eliasziw, M ;

Fischer, M ;

Furlan, A ;

Kaste, M ;

Lees, KR ;

Soehngen, M ;

Warach, S .

STROKE, 2005, 36 (01) :66-73

[8]

HACKE W, 2008, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(08)70267-0

[9] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].

Hacke, Werner ;

Kaste, Markku ;

Bluhmki, Erich ;

Brozman, Miroslav ;

Davalos, Antoni ;

Guidetti, Donata ;

Larrue, Vincent ;

Lees, Kennedy R. ;

Medeghri, Zakaria ;

Machnig, Thomas ;

Schneider, Dietmar ;

von Kummer, Ruediger ;

Wahlgren, Nils ;

Toni, Danilo .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329

[10] Identifying thresholds for penumbra and irreversible tissue damage [J].

Heiss, WD ;

Sobesky, J ;

Hesselmann, V .

STROKE, 2004, 35 (11) :2671-2674

← 1 2 →